© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
616957 |
As an accredited 5-(4-Bromophenyl)-4,6-Dichloropyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-(4-Bromophenyl)-4,6-Dichloropyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
These days, the demand for specialized chemicals keeps growing in both labs and industrial workshops. 5-(4-Bromophenyl)-4,6-Dichloropyrimidine has carved out its place as a trusted intermediate, especially where precision matters most. As someone who’s worked alongside pharmaceutical researchers and chemical engineers, selecting the right intermediate isn’t just about purity, it’s about understanding the backbone of your target compounds. The market may seem crowded with halogen-substituted pyrimidines, but this one stands out for good reason.
The chemical structure holds two chlorine atoms at positions 4 and 6 of the pyrimidine ring and a bromophenyl group at position 5. This combination isn’t chosen by accident — each substitution opens up handling and synthetic flexibility. When researchers work on kinase inhibitors, antineoplastic candidates, or certain agrochemicals, selectivity and reactivity often depend on the placement of each functional group. I’ve seen teams struggle with analogs that either lack the right solubility profile, or introduce side-reactions downstream, wasting both money and weeks of effort. This compound’s well-chosen substitutions can help steer synthesis more predictably.
Purity, particle size, and moisture content influence more than just yield. If the material’s full of unknowns, downstream reactions can easily derail. Reliable suppliers of 5-(4-Bromophenyl)-4,6-Dichloropyrimidine offer several grades, generally featuring purity north of 98%. Analytical techniques like HPLC and NMR confirm structure and quality, and most labs I know insist on independent verification before running important sets of reactions. You won’t get far with an off-spec batch — even a 0.5% impurity can show up as a troublesome byproduct later on, especially during scale-up.
Many manufacturers tweak aspects like particle size or solubility in response to the needs of their customers. While some syntheses run comfortably at room temperature in organic solvents, others call for high-temperature or pressure conditions. The halogen substitutions give chemists a unique handle. They can introduce the compound into Suzuki or Buchwald-Hartwig cross-coupling reactions — processes common to today’s medicinal chemistry. Not all pyrimidine derivatives deliver the same efficiency or compatibility with standard ligands and catalysts. The configuration here supports higher yields and often reduces byproduct headaches common with less stable analogs.
Plenty of pyrimidine derivatives populate the catalogs, but not all behave as required under real-world lab pressure. For example, some rely on alternative halogenation patterns or replace bromine with other groups, and this shifts their electronic properties. In practice, these changes can upend coupling reaction selectivity, alter metabolic stability, or even blunt biological activity. A chemist once told me about wasting several months chasing a fluorinated analog that consistently underperformed in their kinase inhibition assays. By returning to 5-(4-Bromophenyl)-4,6-Dichloropyrimidine, they found the activity profile their lead optimization program needed.
Cost can also become a sticking point. Efficient scale-up and batch consistency mean fewer surprises and steadier pricing. Some seemingly cheaper alternatives come with higher hidden costs — delicate handling demands, problematic crystallization, or unexpected regulatory issues. A clean profile not only ensures lab safety, but also reduces paperwork. This matters more than ever as regulators keep sharpening focus on trace impurities and product documentation.
Medicinal chemists favor this molecule when mapping out new kinase inhibitors and small-molecule modulators. The structure grants room for imagination — both the bromine and the dichloro-substituted pyrimidine ring make fine sites for further derivatization. Downstream, these intermediates head into API (Active Pharmaceutical Ingredient) synthesis, providing a scaffold that can accommodate diverse substitution patterns. Academic teams, often working with tighter budgets, echo these preferences. The ability to reliably transform the halogen groups without running into solubility limits or troublesome side-reactions saves countless hours.
Beyond pharma, this compound shows up in agrochemical research, especially where scientists pursue new crop-protection molecules. Here, the challenge isn’t just biological activity — it’s also regulatory scrutiny and consistent synthesis. Having an intermediate with strong batch-to-batch reliability means fewer revalidation cycles and more predictable field test outcomes. I’ve heard from synthesis managers who dread switching suppliers mid-project, simply because impurities or subtle changes in crystallinity can ripple down to material performance in the field.
I’ve watched labs get caught out by inconsistent quality, especially when sourcing from overseas partners with looser oversight. The best suppliers of 5-(4-Bromophenyl)-4,6-Dichloropyrimidine publish robust COAs (Certificates of Analysis) and participate in transparent audit processes. They respond to questions about synthetic route, impurity profiles, and storage, and they’re willing to offer technical support if trouble crops up mid-project. This improves not only confidence, but reproducibility — a currency more valuable than ever in the age of cross-border collaboration.
Price volatility, often driven by raw material availability or regulatory shifts, sometimes pushes purchasers toward lower-cost options. In practice, these savings can evaporate as labs deal with inconsistent results, failed reactions, or staff time spent chasing down subtle product deviations. I recall a key project delayed nearly two months after a batch of intermediate arrived at half its expected assay value. The lesson: up-front diligence on supplier reputation usually pays off in smoother operations and steadier project timelines.
An often-overlooked concern is environmental and workplace safety. Halogenated aromatics pose unique handling and waste disposal challenges, so teams look for suppliers with detailed safety data and batch documentation. Responsible handlers not only train staff on PPE and ventilation, but also track downstream waste protocols. Studies show that well-managed waste streams can cut compliance risks and keep environmental impact within acceptable bounds.
Chemical innovation builds on access to sophisticated building blocks. 5-(4-Bromophenyl)-4,6-Dichloropyrimidine enables exploration beyond established targets in drug and crop-protection discovery. As molecular targets grow more complex and regulatory requirements more exacting, flexible intermediates like this one open new pathways. Smart use of substitution — leveraging both bromine’s reactivity and the dichlorinated ring — creates opportunities to trial new coupling reactions, hybrid molecules, and delivery profiles.
Developing targeted libraries in-house calls for intermediates that won’t throw curveballs during rapid iteration. As someone who’s helped troubleshoot more than a few reaction conditions, it’s clear that compounds prone to variable impurity or unpredictable behavior can slow everything down, from high-throughput screening to pilot production. By leaning on reliable, well-characterized intermediates, research teams push projects forward with fewer setbacks and tighter timelines.
The open literature and patent filings continue to highlight the importance of pyrimidine chemistry in pharmaceuticals, pesticides, and materials science. Nearly every new generation of kinase inhibitor or antiproliferative agent includes at least one halogenated building block. Reliable access to compounds like 5-(4-Bromophenyl)-4,6-Dichloropyrimidine ensures that pharma and agro teams aren’t forced to improvise around supply gaps or chase elusive performance standards.
Not everyone needs the same intermediate, but some perform far better under real-world stress. Compared with common analogs, the bromophenyl group on this compound extends synthetic and biological versatility. Organic chemists appreciate the opportunity to anchor further substitutions for bespoke targets, taking advantage of the handle it offers for transition metal-catalyzed reactions. Chlorine atoms at positions 4 and 6 fine-tune both electronic effects and solubility, which translates into better control across different solvents, pH ranges, and protocols.
Other dichloropyrimidines look similar at first glance, but the difference lies in the details. Switch out bromine for a different halogen, or shuffle the positions of the chlorine atoms, and you can trigger shifts in reactivity, transformability, and ultimately, biological profile. Generic intermediates might cost less up front, but side reactions and scale-up headaches can undercut those early savings. Workhorse intermediates like this one help labs cut rework and pave the way for versatile discovery campaigns.
No R&D program wants to chase its own tail, and reliable intermediates form the backbone of reproducible research. Ever since preclinical research came under greater scrutiny, teams have demanded both full traceability and clean synthetic lineage for every intermediate. Having worked in environments where audits can arrive with little warning, the difference between a trusted supplier and a risky one becomes painfully clear. Try to justify missing or uncertain batch data, and you risk losing months — even years — of credibility.
The E-E-A-T framework (Experience, Expertise, Authoritativeness, Trustworthiness) outlined by Google isn't just for search engines — it's a solid way to look at product selection. Most seasoned chemists make decisions based on hands-on results and stories from peers. One lab’s nightmare may serve as another lab’s warning. Whenever discussions turn to halogenated pyrimidines, experienced researchers highlight the value of proven performance — an edge this compound provides, especially where scale-up and process validation matter.
Storage and stability count in both shipping and daily use. Most reliable batches of 5-(4-Bromophenyl)-4,6-Dichloropyrimidine arrive in sealed, moisture-proof containers, supplied with lot-specific documentation. Chemists appreciate how the crystalline material handles ordinary lab storage, and solid long-term data supports claims of several months’ shelf life without noticeable degradation. This stands in contrast to more sensitive intermediates known for yellowing, liquefaction, or unexpected reactivity over time.
Handling requirements match those of other halogenated aromatics: gloves and protective eyewear, along with proper fume extraction. Maintaining a low-moisture environment extends usable life and supports reaction reproducibility. As a bonus, the solid form cuts down on risks linked to spills or rapid volatilization. It’s not glamorous, but these factors keep day-to-day operations safer and more predictable, which doesn’t just matter for big pharma — small startups and academic labs benefit just as much.
Labs continue to focus on waste reduction and green chemistry, and intermediates with clean impurity profiles support both. Less purification means fewer solvents, and fewer unknowns means smoother regulatory filings. In some cases, teams exploring continuous flow or in-line analysis need intermediates that won’t gum up their equipment or stall process yields — factors often overlooked by marketing sheets but highlighted repeatedly in real lab feedback. As green chemistry pushes ahead, selecting inputs built on robust, predictable chemistry helps the broader industry move toward smarter, less wasteful processes.
Supply chain reliability becomes more important each year. Unpleasant surprises — delays at customs, sudden shortages, or unexpected changes in quality — can throw off not just one project, but whole research programs. Teams who stake their work on readily available intermediates avoid downtime and budget overruns. This focus on predictability and partnership fosters real progress, both in the short term and for follow-on projects. Sometimes, the real value of a chemical lies not in its shelf price, but in its ability to keep a project on track when timelines matter most.
Building trust in intermediates like 5-(4-Bromophenyl)-4,6-Dichloropyrimidine starts with transparency. Suppliers willing to share synthetic routes, impurity data, and safety details form longer, steadier relationships with their clients. Collaborative efforts — from process improvement to custom packaging or technical troubleshooting — can help both sides avoid the hidden traps that cost money and time. My experience has taught me that establishing open communication between suppliers, buyers, and end-users always shortens the path from the bench to a finished project.
Access to technical documentation and direct advice can save teams from repeating mistakes already solved elsewhere. Sometimes, a choice as simple as an alternative recrystallization solvent or modified storage conditions turns a tricky intermediate into an easy one. Providers who invest in customer support make a difference not just for a single order, but for the learning curve of an entire team. Over time, these relationships help companies and labs adapt — switching up reaction conditions, rethinking safety planning, and staying on the regulatory front foot.
Robust traceability at every stage matters for everyone in the supply chain. Frequent audits, full batch records, and openness about both strengths and limitations allow chemists to match product to purpose, budget, and timeline. My own time managing project transitions has reinforced a simple truth: products that consistently meet or exceed their specifications make every step easier, from initial screening to GMP production. The result is practical peace of mind — no one wants to explain to project leads or regulators why critical data went missing.
As new methods like AI-guided compound selection, automated reaction monitoring, and remote analytics enter mainstream lab practice, the baseline for what labs expect from suppliers rises sharply. Any intermediate hoping to keep pace must not only keep up with higher quality standards, but also offer flexibility, speed, and responsiveness. 5-(4-Bromophenyl)-4,6-Dichloropyrimidine stands out because its pedigree is proven, its profile is understood, and its future potential grows in step with advances in chemistry, pharma, and beyond.
Better chemistry relies on better foundations. Access to reliable intermediates accelerates discovery not just for headline drugs or large-scale agribusiness, but for countless small ventures working on the next big breakthrough. 5-(4-Bromophenyl)-4,6-Dichloropyrimidine enables synthesis plans that reach both short-term milestones and long-haul targets. As the ecosystem around specialty chemicals keeps evolving, industry veterans and newcomers alike seek out partners who can guarantee quality, accountability, and technical depth. By selecting building blocks grounded in experience and evidence, the chemical community paves the way for healthier processes and better project outcomes.
